Company intelligence / Profile preview

Sloane Robinson

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Sloane Robinson was a prominent London-based investment management firm and hedge fund founded in 1993 by Hugh Sloane and George Robinson. The firm specialized in global emerging markets and Asian equities, managing several billion dollars at its peak. While it was a significant player in the financial services sector and invested in various global industries, it was not a life sciences or biotechnology company. In late 2020, the firm announced it would be closing its funds and returning capital to investors, effectively ceasing its primary investment operations.

Industry: Investors

Beyond the preview

Go deeper on Sloane Robinson.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sloane Robinson.

Explore the full profile